Hogan Lovells has advised EyePoint Pharmaceuticals, Inc. on the deal.Cowen and Guggenheim Securities acted as joint book-running managers for the offering. Among other uses, this capital…
EyePoint Pharmaceuticals, Inc.’s US$115 Million Public Offering Of Common Stock
